Arax Advisory Partners’s NRC Health Common Stock NRC Stock Holding History

Arax Advisory Partners’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.4K	Buy	2,245 +2,219	+8,535%	+$41.2K	﹤0.01%	3288
2026 Q1	$442	Sell	26 -53	-67%	-$901	﹤0.01%	3431
2025 Q4	$1.48K	Sell	79 -9,327	-99%	-$141K	﹤0.01%	3369
2025 Q3	$120K	Buy	9,406 +8,910	+1,796%	+$134K	﹤0.01%	1469
2025 Q2	$8.33K	Buy	+496	New	+$6.7K	﹤0.01%	2044
2025 Q1	–	Sell	-44	Closed	-$777	–	2924
2024 Q4	$777	Sell	44 -112	-72%	-$2.12K	﹤0.01%	2223
2024 Q3	$3.57K	Hold	156	–	–	﹤0.01%	1852
2024 Q2	$3.58K	Buy	+156	New	+$4.81K	﹤0.01%	1737

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arax Advisory Partners's NRC Position: Q2 2026 in Review

Arax Advisory Partners increased its NRC Health Common Stock (NRC) stake by 8,535% in Q2 2026, buying an estimated $41.2K and bringing the position to 2,245 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Arax Advisory Partners first reported a position in NRC in Q2 2024 and has held it in 8 quarters since. The position peaked at $120K in Q3 2025. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Arax Advisory Partners held 2,245 shares of NRC Health Common Stock worth $48.4K as of Q2 2026.
Arax Advisory Partners bought 2,219 NRC Health Common Stock shares in Q2 2026, an estimated $41.2K.
NRC Health Common Stock made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3288 holding.
Arax Advisory Partners first reported a position in NRC Health Common Stock in Q2 2024 and has held it in 8 quarters since.
Arax Advisory Partners's NRC Health Common Stock position peaked at $120K in Q3 2025.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.